ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
Dow Jones
41.488,19
1,65%
Euro vs US Dollar
1,09165
0,00%
Bitcoin
84.017,83
-0,39%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Eagle Capital Growth Fund Inc (GRF)

  7. Eagle Capital Growth Fund Inc (GRF) News

GRF

Eagle Capital Growth (GRF)

Eagle Capital Growth Fund Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:GRF
DatumZeitQuelleÜberschriftSymbolFirma
06/03/202518h38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:GRFEagle Capital Growth Fund Inc
06/03/202518h30Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportAMEX:GRFEagle Capital Growth Fund Inc
28/02/202518h10Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
28/02/202516h29Edgar (US Regulatory)Form N-CEN - Annual Report for Registered Investment CompaniesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202519h48Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202519h40Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202519h35Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202519h29Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:GRFEagle Capital Growth Fund Inc
14/01/202512h00GlobeNewswire Inc.Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s DiseaseAMEX:GRFEagle Capital Growth Fund Inc
26/12/202419h40Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]AMEX:GRFEagle Capital Growth Fund Inc
05/12/202421h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
19/11/202414h00GlobeNewswire Inc.GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B VirusAMEX:GRFEagle Capital Growth Fund Inc
18/11/202422h00Business WireEagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in CashAMEX:GRFEagle Capital Growth Fund Inc
29/10/202413h00GlobeNewswire Inc.Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant SolutionAMEX:GRFEagle Capital Growth Fund Inc
22/10/202414h00GlobeNewswire Inc.Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye InjuryAMEX:GRFEagle Capital Growth Fund Inc
03/10/202416h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
03/10/202414h00GlobeNewswire Inc.GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional BiothreatAMEX:GRFEagle Capital Growth Fund Inc
10/09/202419h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
10/09/202419h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
29/08/202420h08Edgar (US Regulatory)Form N-PX - Annual Report of proxy voting record of management investment companiesAMEX:GRFEagle Capital Growth Fund Inc
20/08/202420h02Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
31/07/202414h00GlobeNewswire Inc.GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339AMEX:GRFEagle Capital Growth Fund Inc
29/07/202414h00GlobeNewswire Inc.Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patientsAMEX:GRFEagle Capital Growth Fund Inc
01/07/202412h00GlobeNewswire Inc.Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven yearsAMEX:GRFEagle Capital Growth Fund Inc
18/06/202413h30GlobeNewswire Inc.Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier GroupAMEX:GRFEagle Capital Growth Fund Inc
17/06/202410h20GlobeNewswire Inc.Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficienciesAMEX:GRFEagle Capital Growth Fund Inc
24/05/202421h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
18/04/202415h30GlobeNewswire Inc.Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.AMEX:GRFEagle Capital Growth Fund Inc
04/04/202410h00GlobeNewswire Inc.Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus ScreeningAMEX:GRFEagle Capital Growth Fund Inc
07/03/202417h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:GRFEagle Capital Growth Fund Inc
 Showing the most relevant articles for your search:AMEX:GRF

Kürzlich von Ihnen besucht

NASDAQ
FEEPX
Bmo Selecttrust Conserva...
EU
STN
Spdr Msci Europe Energy ...
NASDAQ
LEDS
SemiLEDS
AQEU
CLARIP
Clariane
TG
4I1E
Phillip Morris
COIN
NIOUSD
Autonio
COIN
ACRUSD
Acreage
TG
TEPT
Franklin Templeton Inter...
ASX
XAT
S&P ASX All Australian 200
KOSPI
181710
NHN Entertainment
DOWI
DWMFUT
DJ Middle East & Africa ...
NASDAQ
AGAE
Allied Gaming and Entert...
DOWI
DJTMDIT
DJ Media Titans 30 Total...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten